Faculty member, Dr. Oleh Taratula and his research group received an R21 grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development along with Ov Slayden from the ONPRC titled “A nanoparticle-based approach for surgical imaging and intraoperative treatment of endometriosis” with a 6th percentile score. Faculty member, Dr. Oleh Taratula and his […]
Dr. BJ Philmus received funding from the Joint Genome Institute to study triazine natural products.
Dr. Taifo Mahmud of the graduate program in Pharmaceutical Sciences and Richard Van Breemen of the Linus Pauling Institute at OSU received a new T32 training grant from the NIH, National Center for Complementary and Integrated Health
In collaboration with Deepa Rao at Pacific entitled “Mitigation of Doxorubicin-Induced Cardiotoxicity by Phytochemicals in Micelles” Congratulations!
Drs. Jane Ishmael and Kerry McPhail, Associate Professors of Pharmacology and Medicinal Chemistry/Natural Products, respectively, in the Department of Pharmaceutical Sciences, received NIH R01 funding for $1.6 million to pursue natural products drug discovery research for a project titled “Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands.” Drs. Ishmael and McPhail are […]
Dr. Gaurav Sahay, an assistant professor of Drug Delivery and Nanotherapeutics in the Department of Pharmaceutical Sciences based on our Portland campus, received a 5-year, $3.3 million R01 grant from National Institutes of Health. Sahay’s project, “Nanoparticle-based mRNA delivery for treatment of cystic fibrosis,” is to develop a novel, inhalable system capable of delivering mRNA […]